Inhibitory effects of bifemelane on brain Ca2+ channel subtypes expressed in Xenopus oocytes

Japanese Journal of Pharmacology

Volumn 78, Issue 1, 1998, Pages 39-44

  Kinoshita, Mariko ^a   Kaneko, Shuji ^a   Yasuno, Tohru ^a   Yada, Nobumichi ^a   Akaike, Akinori ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bifemelane; N type; Q type; Voltage dependent Ca2+ channel; Xenopus oocyte

Indexed keywords

BIFEMELANE; CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; BRAIN; CALCIUM CURRENT; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; OOCYTE; XENOPUS;

EID: 0031661191     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.39     Document Type: Article

References (28)

1. Tazaki Y, Kutsuzawa N, Tohgi H, Goto F, Ohtomo E, Hasegawa K, Nukada T, Yamaguchi T and Omae T: Clinical evaluation of E-0687 on cerebrovascular disease (late phase II study). Jpn J Clin Exp Med 61, 2717-2733 (1984)
2. Satoh M, Ishihara K and Katsuki H: Different susceptibilities of long-term potentiations in CA3 and CAl regions of guinea pig hippocampal slices to nootropic drugs. Neurosci Lett 93, 236-241 (1988)
3. Fujii T, Kuraishi Y, Okada T and Satoh M: Bifemelane induces translocation protein kinase C in the CA3, but not the CA1, region of guinea pig hippocampus. Can J Physiol Pharmacol 68, 413-418 (1990)
4. Miyazaki S, Katayama Y, Furuichi M, Kinoshita K, Kawamata T and Tsubokawa T: Impairment of hippocampal long-term potentiation following transient cerebral ischaemia in rat: effect of bifemelane, a potent inhibitor of ischaemia-induced acetylcholine release. Neurol Res 15, 249-252 (1993)
5. Saito K, Honda S, Egawa M and Tobe A: Effects of bifemelane hydrochloride (MCI-2016) on acetylcholine and norepinephrine release from cortical slices of bilaterally carotid-artery-ligated Mongolian gerbils. Jpn J Pharmacol 39, 406-409 (1985)
6. Ogawa N, Haba K, Yoshikawa H, Ono T and Mizukawa K: Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced depletion of brain acetylcholine levels in gerbils. Res Commun Chem Pathol Pharmacol 61, 285-288 (1988)
7. Gu GS, Mizushima H, Arai Y, Shimazu M, Matsumoto K, Shioda S and Nakai Y: Protective effect of bifemelane on c-Fos-like immunoreactivity in rat cerebral ischemia. Brain Res Bull 34, 243-247 (1994)
8. Akaike A, Maeda T, Kume T and Kaneko S: Bifemelane protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Jpn J Pharmacol 76, 313-316 (1998)
9. 2+ channels more than stamp collecting? Trends Pharmacol Sci 18, 363-371 (1997)
10. 2+ channels: effects of bifemelane and several nootropic agents. Eur J Pharmacol 189, 51-58 (1990)
11. Ferrendelli JA and Daniels-McQueen S: Comparative actions of phenytoin and other anticonvulsant drugs on potassium- and veratridine-stimulated calcium uptake in synaptosomes. J Pharmacol Exp Ther 220, 29-34 (1982)
12. Leslie SW, Chandler LJ, Chweh AY and Swinyard EA: Correlation of the hypnotic potency of benzodiazepines with inhibition of voltage-dependent calcium uptake into mouse brain synaptosomes. Eur J Pharmacol 126, 129-134 (1986)
13. Mori Y, Friedrich T, Kim M, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T and Numa S: Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350, 398-402 (1991)
14. Fujita Y, Mynlieff M, Dirksen RT, Kimn M, Niidome T, Nakai J, Friedrich T, Iwabe N, Miyata T, Furuichi T, Furutama D, Mikoshiba K, Mori Y and Beam KG: Primary structure and functional expression of the ω-conotoxin-sensitive N-type calcium channel from rabbit brain. Neuron 10, 585-598 (1993)
15. Mikami A, Imoto K, Tanabe T, NiidomeT, Mori Y, Takeshima H, Narumiya S and Numa S: Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 340, 230-233 (1989)
16. 2+ channels expressed in Xenopus oocytes. Neurosci Lett 217, 13-16 (1996)
17. 2+ channel currents expressed by Xenopus oocyte after injection of brain mRNA. Neurosci Lett 83, 123-127 (1987)
18. 1 subunits. Br J Pharmacol 121, 806-812 (1997)
19. Ikeda SR: Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits. Nature 380, 255-258 (1996)
20. Moreno H, Rudy B and Llinás R: β Subunits influence the biophysical and pharmacological differences between P- and Q-type calcium currents expressed in a mammalian cell line. Proc Natl Acad Sci USA 94, 14042-14047 (1997)
21. 2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol 122, 37-42 (1997)
22. Gundersen CB, Umbach JA and Swartz BE: Barbiturates depress currents through human brain calcium channels studied in Xenopus oocytes. J Pharmacol Exp Ther 247, 824-829 (1988)
23. Minami M, Arai H, Takahashi T, Kimura M, Noguchi I, Suzuki T and Inoue R: A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders. Prog Neuropsychopharmacol Biol Psychiatry 19, 59-64 (1995)
24. Bowersox SS, Singh T and Luthr RR: Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res 747, 343-347 (1997)
25. 2+ channel blocker ω-agatoxin IVA protects against brain injury after focal ischemia in rats. Brain Res 776, 140-145 (1997)
26. Harvey J, Wedley S, Findlay JD, Sidell MR and Pullar IA: ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices. Neuropharmacology 35, 385-392 (1996)
27. 3H]acetylcholine release in rat hippocampal slices. Brain Res Bull 40, 283-286 (1996)
28. Choi DW and Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13, 171-182 (1990)